Showing 1-10 of 670
Recognizing employee excellence that carries ‘the legacy of military medicine’
Feb. 04, 2026
The ceremony recognized the exceptional work of service members and civilians and those earning Continuous Process Improvement certifications.
CDC issues nationwide health advisory on New World screwworm
Feb. 02, 2026
The CDC issued a nationwide health alert Network Health Advisory to share information about the New World screwworm.
Forensic toxicology reinforces joint standards
Jan. 30, 2026
AFMES’ Forensic Toxicology division runs and maintains the DOW’s only American Board of Forensic Toxicology International Organization for Standardization accredited laboratories.
Nurse receives prestigious WBAMC award
Jan. 29, 2026
The Light the Way award was re-ignited last year to celebrate nurses within the organization.
U.S. Military senior medical leaders from across Europe take part in senior leader forum
Jan. 27, 2026
The three-day event aimed to operationalize data for medical organizations operating in, and supporting, the USEUCOM and USAFRICOM areas of responsibility.
Freeze-dried plasma meets needs of Joint Force, Combatant Commands for future conflicts
Jan. 26, 2026
Most of WPAC’s efforts centers on delivering blood products to fill existing capability gaps for frontline providers across the Department of War.
DHA launches Patient Advocate Assistance Reporting Tool to ‘make sure that our patients’ voices are being heard’
Jan. 23, 2026
The primary goal of PAART is to use patient feedback provided to drive improvements within military hospitals and clinics.
New clinical practice guideline recognizes insomnia and sleep apnea can occur together
Jan. 22, 2026
The CPGs are designed to help primary care health professionals use the most up-to-date and evidence-based disease identification and treatment options.
Retirement changes your TRICARE coverage: Learn what to do if you’re retiring in 2026
Jan. 22, 2026
When you retire from active duty or the National Guard or Reserve, you experience a TRICARE Qualifying Life Event.
USAMRIID collective study demonstrates potential broad-spectrum anti-alphavirus therapeutics
Jan. 21, 2026
A mosquito-borne alphavirus, VEEV can cause a spectrum of disease from mild febrile flu-like illness to neurological symptoms in 4%–14% of infected individuals.